Switching patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) with residual disease on long-term imatinib (IM) to nilotinib (NIL): ENESTcmr 24-mo follow-up Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Spector, Nelson
  • Leber, Brian
  • Lipton, Jeffrey Howard
  • De Souza, Carmino
  • Moiraghi, Beatriz
  • Steegmann, Juan Luis
  • Schwarer, Anthony P
  • Cervantes, Francisco
  • Hughes, Timothy P
  • Purkayastha, Das
  • Collins, LaTonya R
  • Szczudlo, Tomasz K
  • Rea, Delphine

publication date

  • May 20, 2013